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Incidence Trends of Squamous Cell and Rare Skin
Cancers in the Swedish National Cancer Registry
Point to Calendar Year and Age-Dependent Increases
Shehnaz K. Hussain1, Jan Sundquist2,3 and Kari Hemminki2,4
Little is known regarding the incidence trends of squamous cell skin carcinoma (SCC) and rare skin tumors,
including Merkel cell carcinoma (MCC) and dermatofibrosarcoma protuberans (DFSP). The purpose of this
study was to examine recent incidence trends for these cancers from 1990 to 2005 using the population-based
Swedish National Cancer Registry. SCC incidence increased significantly over the study period and increased
sharply with age. MCC incidence increased significantly for men for tumors at sun-exposed sites, and increased
sharply with age. DFSP incidence was similar for sun-exposed and covered sites and decreased significantly only
at exposed sites. A combination of behavioral, biological, and environmental factors likely explains the trends
observed for these skin cancers.
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INTRODUCTION
Squamous cell skin carcinoma (SCC) accounts for approxi-
mately 8% of new cancer diagnoses in Sweden, making it the
second most commonly diagnosed cancer among men and
third among women (Center for Epidemiology, 2007). Even
more striking is that the incidence of these cancers has been
rapidly increasing over the past half century, which is a trend
common to other Caucasian populations (Trakatelli et al.,
2007). Thus, up-to-date reporting on SCC incidence trends is
important for tracking and predicting the future burden of
these cancers. The Swedish Cancer Registry has captured
incidence data on these cancers since 1958. We have used
this resource to explore incidence trends for SCC, together
with more rare skin cancers including Merkel cell carcinoma
(MCC) and dermatofibrosarcoma protuberans (DFSP).
SCC risk is positively associated with cumulative exposure
to ultraviolet radiation from sunlight and artificial tanning
lamps (Preston and Stern, 1992; Karagas et al., 2002). Other
risk factors for SCC include fair skin (English et al., 1998),
arsenic exposure (Yu et al., 2006), immunosuppres-
sive conditions (Jensen et al., 1999; Karagas et al., 2001;
Crum-Cianflone et al., 2009), chronic diseases, (Jensen et al.,
2008), and cutaneous viral infections (Harwood and Proby,
2002). SCC risk is also positively associated with age and
male sex; however, women are also greatly affected
(Wassberg et al., 2001; Hemminki et al., 2003).
The etiologies of rare skin cancers are far less understood.
MCC is an aggressive neuroectodermal tumor of the skin that
is positively associated with male sex and age (Agelli and
Clegg, 2003). In addition, immunosuppressed individuals,
including transplant recipients and HIV-infected individuals,
have an increased risk of this tumor (Engels et al., 2002).
Recently, a novel polyomavirus has been identified that is
clonally integrated in MCC tumors and thus thought to be an
important contributing factor to MCC pathogenesis (Feng
et al., 2008). Ultraviolet radiation is an additional important
risk factor for MCC (Pectasides et al., 2006).
DFSP is a rare and locally aggressive soft tissue sarcoma
that has a tendency to recur, yet with limited metastatic
potential (Dimitropoulos, 2008). Incidence rates are gener-
ally similar for men and women, and are highest between the
second and fifth decade of life (Monnier et al., 2006). The
etiology of this tumor is very poorly understood. Previous
trauma, burning, or scarring may predispose to future
development of DFSP at the same site (Yu et al., 2008).
Population-based incidence rates for SCC have rarely been
described in the literature on account of lack of registration
by most national cancer registries. Moreover, there are no
recent reports of SCC and rare skin cancer incidence trends
that extend through 2005. Thus, we used the Swedish
National Cancer Registry to calculate recent trends in
incidence of these skin cancers. Furthermore, given that the
risk of many of these skin tumors is positively associated with
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ultraviolet radiation exposure, we explored incidence trends
separately for tumors occurring on sun-exposed versus
covered sites.
RESULTS
Over the entire study period (1990–2005), men had a higher
incidence of SCC, MCC, and DFSP when compared with
women (Table 1). Incidence of SCC and MCC increased with
age and DFSP incidence was highest among those diagnosed
ato65 years of age. The incidence rate for SCC occurring on
the head and neck was higher when compared with the
relatively similar incidence rates for tumors occurring on the
trunk, arms, and legs. The incidence of MCC was also highest
for tumors occurring on the head and neck, whereas DFSP
incidence was highest for tumors on the trunk.
Between 1990 and 2005, the incidence of SCC increased
significantly for both men and women at sun-exposed
and covered sites (Table 2 and Figure 1). For tumors at
sun-exposed sites, SCC incidence increased from 24.4 to
45.0 per 100,000 person-years (184% overall, 3.7 average
annual percent change (AAPC)) for men and 10.6 to 23.6
per 100,000 person-years (222% overall, 5.3 AAPC) for
women. Similarly, for tumors at covered sites, SCC incidence
increased from 2.3 to 9.2 per 100,000 person-years (400%
overall, 7.7 AAPC) for men and 0.8 to 2.6 per 100,000 (325%
overall, 8.5 AAPC) for women.
SCC incidence at sun-exposed sites increased sharply with
age (Figure 2). Incidence rates were highest for men and
women of X85 years of age for exposed and covered sites,
and age-specific incidence rates increased with increasing
diagnosis year. From 1990–1994 to 2000–2005, e.g., the
incidence of invasive SCC at sun-exposed sites among those
who were X85 years of age increased from 384.7 to 586.7
per 100,000 person-years (153%) for men and 171.5 to 273.5
per 100,000 person-years (159%) for women. The incidence
rates for tumors at covered sites did not rise as sharply with
age when compared with the incidence of tumors at sun-
exposed sites. Furthermore, the AAPC increase for SCC was
generally greater for individuals X85 years of age when
compared with those who were o85 years (Table 2).
A few trends were also observed for rare skin tumors
(Table 2, Figure 3). For men and women combined, there
were no significant changes in MCC incidence over the
study period; however, only the AAPC reached statistical
significance for those o85 years (3.3; 2.8–3.9 AAPC) and
X85 (4.6; 3.7–5.5 AAPC) (data not shown). Incidence rates
for DFSP decreased significantly over time for tumors at
sun-exposed sites, –4.4 AAPC, which was similar for both
men and women (data not shown). Similar to SCC, the
incidence rates for MCC were dependent on age; the
incidence increased dramatically after the age of 50 years
(Figure 4).
DISCUSSION
We have used a large population-based national registry to
examine recent trends in skin cancer incidence in Sweden.
Table 1. Age-adjusted incidence rates for invasive skin tumors from 1990 to 2005 by sex, age group, and tumor site
Squamous cell skin carcinoma Merkel cell carcinoma Dermatofibrosarcoma
n
Incidence per 100,000
person-years (95% CI) n
Incidence per 100,000
person-years (95% CI) n
Incidence per 100,000
person-years (95% CI)
Sex
Men 22,642 34.4 (34.4–34.5) 171 0.42 (0.41–0.43) 209 0.44 (0.43–0.45)
Women 14,679 15.4 (15.3–15.4) 205 0.33 (0.32–0.33) 196 0.40 (0.39–0.40)
Age
p64 5,015 4.02 (4.01–4.03) 36 0.05 (0.05–0.05) 321 0.40 (0.39–0.40)
65–84 22,667 9.00 (8.99–9.00) 233 0.15 (0.14–0.15) 73 0.05 (0.05–0.05)
X85 9,639 26.9 (26.9–26.9) 108 0.45 (0.45–0.45) 11 0.05 (0.05–0.05)
X85 (%) 25.8% 28.6% 2.7%
Tumor site
Head and neck 24,811 89.3 (89.2–89.5) 185 0.79 (0.78–0.81) 61 0.38 (0.37–0.39)
Trunk 3,421 12.3 (12.3–12.4) 55 0.33 (0.32–0.34) 161 0.83 (0.82–0.85)
Arms 4,581 16.5 (16.4–16.5) 70 0.39 (0.38–0.39) 82 0.48 (0.47–0.49)
Legs 2,822 10.2 (10.1–10.3) 50 0.29 (0.28–0.30) 66 0.41 (0.40–0.42)
Multifocal 625 2.57 (2.55–2.59) 0 0
Unknown 1,061 3.99 (3.96–4.01) 16 0.10 (0.10–0.11) 35 0.23 (0.22–0.23)
Abbreviations: n, number of cases; CI, confidence interval.
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Several key findings have emerged. SCC incidence increased
from 1990 to 2005 at an alarming rate for men and women at
both sun-exposed and covered tumor sites. The average
annual percent increase was greatest for tumors at covered
sites: 7.7% annually for men and 8.5% for women. In
addition, we have shown that SCC and MCC incidence rates
are extremely age dependent. Lastly, our data show that DFSP
incidence at sun-exposed sites has decreased significantly
with time, whereas MCC incidence has increased signi-
ficantly among men for tumors at sun-exposed sites.
This study builds upon a previous body of literature
examining trends in SCC incidence in earlier time periods.
In one study of invasive SCC incidence in Sweden from
1961 to 1995, the authors reported a significant 3.1%
annual increase in incidence for men, and 2.6% increase
for women (Wassberg et al., 2001). Another study reporting
on similar years found a dramatic increase in incidence
among women for tumors at covered sites (Hemminki et al.,
2003).
We found that in more recent years, incidence rates of
SCC are far higher than previous reports from earlier time
periods, and that the rate of increase is also higher. The
highest incidence rates were observed for SCC tumors at
sun-exposed sites. This is likely due, in part, to increases in
exposure to ultraviolet radiation on account of increased
vacationing to sunny locations (Boldeman et al., 2001), and
possibly environmental changes such as ozone depletion
(Dal et al., 2008). The higher incidence rates observed in
men when compared with women is similar to previous
reports and may be on account of different behavior patterns
of sun exposure. Historically, e.g., men were more likely
than women to work outdoors, which could explain why
older men experienced the highest incidence rates of SCC.
Alternatively, ultraviolet radiation may have sex-specific
effects (Perez-Gomez et al., 2008).
The fact that the relative changes by calendar year were
greatest for tumors at covered sites suggests an increase in
behaviors such as tanning and use of sunbeds over time. One
study conducted in 1999 in Sweden reported that on average
33% of women and 17% of men intentionally tan outdoors.
In 2001, another study was conducted in Sweden that
reported that 56% of women and 38% of men intentionally
tan outdoors often to very often, which suggests that outdoor
tanning may be increasing over time (Branstrom et al., 2006).
The 1999 study also reported that 41% of Swedish women
and 25% of Swedish men use sunbeds (Boldeman et al.,
2001). Alternatively, there may be other environmental
exposures outside of ultraviolet radiation exposure that have
increased over time and may predispose to SCC. Recent
studies, e.g., reported increased risk of SCC associated with
previous hospitalization for inflammatory diseases, such as
asthma, rheumatoid arthritis, and Crohn’s disease, linking
SCC risk with immunological disturbances (Ji et al., 2009;
Hemminki et al., 2009a, b). As with increasing trends in
allergies, the trends in SCC may be explained by an increa-
sing state of general immunological impairment in the
Swedish population. Lastly, the increase in SCC incidence
may be partially explained by an increased awareness of skin
cancer by both patients and their practitioners, leading
to diagnosis of slow-progressing tumors that may have gone
undiagnosed in previous years.
The extreme age dependence of SCC and MCC is striking,
and seems much stronger than other cancers. In Sweden,
e.g., in 2006, 26.1% of male and 37.2% of female skin
cancers (excluding basal cell carcinomas and melanomas)
were diagnosed in people aged X85 years. The comparative
figures for all cancers combined were 8.6 and 11.2%,
respectively. Interestingly, this difference has increased over
Table 2. Average annual percent change in age-
adjusted incidence rates (per 100,000 person-years)
for invasive skin cancers between 1990 and 2005 in
Sweden
Total population o85 Years X85 Years
Squamous cell skin carcinoma
Men
exposed
3.7 (3.1–4.3) 3.3 (2.8–3.9) 4.6 (3.7–5.5)
Women
exposed
5.3 (3.8–6.9) 4.5 (3.8–5.2) 6.0 (4.2–7.8)
Men
covered
7.7 (6.3–9.2) 6.3 (5.1–7.6) 13.7 (11.2–16.2)
Women
covered
8.5 (7.1–9.8) 9.8 (6.5–13.1) 8.2 (4.4–12.0)
Merkel cell carcinoma
Exposed 3.2 (0.3 to 6.8) 1.9 (1.6 to 5.6) 4.6 (0.8 to 10.3)
Covered 0.8 (5.4 to 7.3) 0.5 (5.5 to 4.8) 1.5 (2.2 to 5.4)
Dermatofibrosarcoma
Exposed 4.4 (7.6 to 1.0) 3.9 (7.1 to 0.6) Too few cases
Covered 0.3 (3.1 to 4.0) 0.3 (6.0 to 5.6) Too few cases
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Figure 1. Age-adjusted incidence trends of squamous cell skin cancer for
sun-exposed and covered tumor sites by sex in Sweden between 1990 and
2005.
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the years. In 1990, the figures for skin cancer were 15.0% for
males and 27.6% for females, whereas the figures for all
cancers were 6.6 and 7.8%, respectively. Immunological
deterioration with advanced aging is a likely explanation for
the age-specific incidence trends for these cancers (Castle
et al., 2007). With population projections predicting a
significant increase in the elderly population, skin cancer
will continue to be a growing public health problem.
Similar to previous reports, DFSP incidence rates were
comparable between men and women, and highest for
tumors occurring on the trunk (Monnier et al., 2006;
Dimitropoulos, 2008; Kampshoff and Cogbill, 2009). How-
ever, interestingly, we found that DFSP incidence was
decreasing significantly over time for tumors at sun-exposed
sites, yet there is no clear explanation for this. A recent study
reported that DFSP incidence rates increased among whites
in the United States in the 1970s and 1980s, followed by a
leveling off in the 1990s (Criscione and Weinstock, 2007).
These authors attributed the increase and leveling off to
improved reporting and immunohistological identification of
these tumors over time; however, this would not explain the
decrease that we observed in our study.
Our findings that MCC occurs more frequently in older
men and is most often found on the head and other sun-
exposed sites has been described in previous studies
(Kampshoff and Cogbill, 2009; Vilar-Coromina et al., 2009).
Our data also show that the incidence of MCC at exposed
sites for men is significantly increasing over time. This may be
a reflection of the important role of ultraviolet radiation in
MCC etiology as a cofactor to Merkel cell polyomavirus.
An important limitation of this study is lack of person-level
data on sun exposure or sun sensitivity and thus a reliance
on anatomical tumor site as a surrogate for the relation-
ship between UVR and cancer risk. The main strengths
of this study are the nationwide coverage and complete
ascertainment of incident skin cancer cases, which allows
us to make population-based inferences. The large number
of cases enables us to find epidemiologic patterns and
trends that were of statistical significance for uncommon
cancers.
In conclusion, a combination of behavioral (e.g., vaca-
tioning and tanning), biological (e.g., aging), and environ-
mental (e.g., ozone depletion) changes may explain the
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Figure 2. Incidence trends of squamous cell skin cancer for sun-exposed and covered tumor sites by sex, 5-year age groups, and diagnosis year in Sweden
between 1990 and 2005.
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Figure 3. Age-adjusted incidence trends of rare invasive skin cancer for
sun-exposed and covered tumor sites in Sweden between 1990 and 2005.
35–
0.0
1.0
2.0
3.0
4.0
5.0
6.0
7.0
In
ci
de
nc
e 
pe
r 1
00
,0
00
 p
er
so
n-
ye
ar
s
39 44 49 54 59 64 69 74 79 84
Age group (in years)
Exposed site Covered site
40– 45– 50– 55– 60– 65– 70– 75– 80– 85+
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incidence trends observed in this study. Studies aimed at
elucidating the specific risk factors for these cancers will be
critical for developing interventions to reduce the burden of
these cancers in the future.
MATERIALS AND METHODS
Study population and cancer ascertainment
The study population consisted of all residents of Sweden from 1990
to 2005, who contributed 51,146,364 person-years of follow-up.
Cancer incidence data by calendar year were derived from the
Swedish National Cancer Registry. Invasive skin cancers were
identified by the first three digits of the seventh revision of the
International Classification of Diseases, code 191. Broad histopatho-
logical classifications based on WHO/HS/CANC/24.1 coding
(Organization, 1956) was used to identify and differentiate invasive
SCC (code 146), invasive MCC (code 446), and invasive DFSP (code
715). Nearly 100% of all skin cancers diagnosed during the study
period were histologically verified on account of compulsory
nationwide registration by clinicians, pathologists, and cytologists
(Center for Epidemiology, 2007). In total, 37,321 invasive SCCs,
376 MCCs, and 405 DFSP were identified.
Statistical analysis
Age-adjusted incidence rates were obtained through direct
standardization with the Swedish 2000 population (see Supplemen-
tary Table S1 online). Age-adjusted incidence rates and correspond-
ing 95% confidence intervals were calculated for the entire study
period by sex, age group, and anatomical tumor site. Calendar year-
specific age-adjusted incidence rates were calculated, stratified by
sun-exposed versus covered tumor site. Incidence rates were also
stratified by sex. However, on account of the low frequency of
MCC and DFSP, these incidence data are presented aggregated
over both sexes. The anatomical tumor site was determined by the
fourth digit of the International Classification of Diseases code: head
and neck (1911–1914), trunk (1915), arms (1916), legs (1917),
multifocal (1918), and not specified (1919). For this study, sun-
exposed sites were defined as tumors occurring on the head, neck,
and arms. For women, legs were also considered sun exposed. All
other tumor sites, excluding multifocal and not specified, were
considered covered. Multifocal and not specified tumors sites were
excluded.
Joinpoint regression analysis was used to quantify the change in
age-adjusted incidence rates by calendar year (Kim et al., 2000). The
method uses weighted least squares log-linear regression analysis
with calendar year as the independent variable and age-adjusted
incidence rates as the dependent variable to identify time points
at which statistically significant changes in incidence rates occur.
The best fitting model is selected based on a Bonferroni adjusted
permutation test to maintain an overall two-sided P-value ofo0.05.
Annual percent change and corresponding 95% confidence interval
for each joined line segment were estimated, along with the AAPC,
which is the weighted average of the annual percent change for all
line segments. We chose to present the AAPC for the entire study
population, and separately for those aged o85 and X85 years to
highlight the burden of these cancers in the elderly.
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